clinical trial · NCT06685692
A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)
Alcohol HepatitisADX-629ADX-629
brief summary
A Phase 2 Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjects with Moderate Alcohol Associated Hepatitis (Part 1)
started
Nov 4, 2024
primary completion
Jun 18, 2025
completion
Jun 18, 2025
last updated
Dec 12, 2025
official title
A Phase 2 Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjects With Moderate Alcohol Associated Hepatitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol